SEC Form 4 · accession 0001140361-17-008940
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Demane
Director
Period of report
Feb 21, 2017
Accepted (ET)
Feb 23, 2017 · 9:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 21, 2017 | S | 1,745 | $97.30 | D | 524,175 | D | |
| Common StockF2 | Feb 21, 2017 | S | 4,255 | $97.30 | D | 0 | I | See footnote |
| Common StockF3 | holding | — | — | — | 72,554 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- F2Shares held by The Michael F. DeMane 2013 Retained Annuity Trust.
- F3Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.